Awardee OrganizationUNIV OF NORTH CAROLINA CHAPEL HILL
Description
Abstract Text
The research aims at elucidating the role of vanilloid receptors (VR) in the mediation of nociception in the dorsal horn of mammals. Immunocytochemistry of the VR1 receptor has shown that this is expressed mainly in small cells of dorsal root ganglia and in afferents to the superficial laminae of the dorsal horn. VR1-immunopositive terminals predominate in lamina I and are present in lamina II. In this lamina, however, most of the staining for VR1 is in dendrites postsynaptic to primary afferents. It was also established that VR1 terminals do not contain substance P (SP). Thus, two main classes of afferents may mediate nociception and the question arises whether they contact the same neurons. This will be established by studying, with confocal microscopy and electron microscopy, whether VR1- and SP-immunopositive terminals contact the same neuron expressing neurokinin receptors (NK1) in lamina I. It is predicted that, if VR1-positive afferents mediate nociception, these neurons will project to the parabrachial nucleus, a major destination for ascending nociceptive pathways in rodents. The research will also establish what glutamate receptor subunits are present at VR1-positive synapses in superficial laminae. In particular, the absence of NMDA receptor would signify a clearly different role for these synapses from that of afferents that release SP. Also this part of the research will require simultaneous multiple labeling at the light and electron microscopic level. The third aim of the research is to test whether postsynaptic VR1 is related to activity in C fibers, independently from its origin, i.e. from intrinsic neurons or via transsynaptic traffic. The total depletion of VR1 in the dorsal horn after dorsal rhizotomy suggests an activity dependency of postsynaptic VR1 and this will be tested by conduction block of dorsal roots and, conversely, by selective activation of C fibers with cutaneous application of mustard oil.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
608195277
UEI
D3LHU66KBLD5
Project Start Date
15-July-2001
Project End Date
30-June-2005
Budget Start Date
15-July-2001
Budget End Date
30-June-2002
Project Funding Information for 2001
Total Funding
$245,616
Direct Costs
$175,000
Indirect Costs
$70,616
Year
Funding IC
FY Total Cost by IC
2001
National Institute of Neurological Disorders and Stroke
$245,616
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01NS040885-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01NS040885-01A1
Patents
No Patents information available for 1R01NS040885-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01NS040885-01A1
Clinical Studies
No Clinical Studies information available for 1R01NS040885-01A1
News and More
Related News Releases
No news release information available for 1R01NS040885-01A1
History
No Historical information available for 1R01NS040885-01A1
Similar Projects
No Similar Projects information available for 1R01NS040885-01A1